[1]
|
Ganeshan, D., Kambadakone, A, Nikolaidis, P., Subbiah, V., Subbiah, I.M. and Devine, C. (2021) Current Update on Gallbladder Carcinoma. Abdominal Radiology, 46, 2474-2489. https://doi.org/10.1007/s00261-020-02871-2
|
[2]
|
Roa, J.C., Basturk, O. and Adsay, V. (2021) Dysplasia and Car-cinoma of the Gallbladder: Pathological Evaluation, Sampling, Differential Diagnosis and Clinical Implications. Histo-pathology, 79, 2-19.
https://doi.org/10.1111/his.14360
|
[3]
|
Sons, H.U., Borchard, F. and Joel, B.S. (1985) Carcinoma of the Gallblad-der: Autopsy Findings in 287 Cases and Review of the Literature. Journal of Surgical Oncology, 28, 199-206. https://doi.org/10.1002/jso.2930280311
|
[4]
|
窦常伟, 张成武. 腹腔镜胆囊癌根治术的临床应用体会及思考[J]. 肝胆胰外科杂志, 2020, 32(5): 270-273, 276.
|
[5]
|
Peng, H., Fan, K., Zan, R., Gong, Z.J., Sun, W., Sun, Y., Wang, W., Jiang, H., Lou, J., Ni, J., Suo, T. and Zhang, X. (2021) Degradable Magnesium Implants Inhibit Gallbladder Cancer. Acta Biomaterialia, 128, 514-522.
https://doi.org/10.1016/j.actbio.2021.04.051
|
[6]
|
Henson, D.E., Albores-Saavedra, J. and Code, D. (1992) Carci-noma of the Gallbladder. Histologic Types, Stage of Disease, Grade, and Survival Rates. Cancer, 70, 1493-1497,
https://doi.org/10.1002/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U
|
[7]
|
Nimura, Y. (2002) Extended Surgery in Bilio-Pancreatic Cancer: The Japanese Experience. Seminars in Oncology, 29, 17-22. https://doi.org/10.1016/S0093-7754(02)70022-5
|
[8]
|
Malenica, I., Donadon, M. and Lleo, A. (2020) Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift towards a Personalized Medicine. Can-cers, 12, Article No. 2190.
https://doi.org/10.3390/cancers12082190
|
[9]
|
Ausania, F., Tsirlis, T., White, S.A., French, J.J., Jaques, B.C., Charnley, R.M. and Manas, D.M. (2013) Incidental pT2-T3 Gallbladder Cancer after a Cholecystectomy: Outcome of Staging at 3 Months Prior to a Radical Resection. HPB (Oxford), 15, 633-637. https://doi.org/10.1111/hpb.12032
|
[10]
|
Tange, S., Hakuta, R., Nakai, Y., Oyama, H., Noguchi, K., Ito, Y., Bae, Y., Kumasaka, T. and Yoshida, H. (2021) A Rare Case of Gallbladder Cancer with Multiple Metastases to the Colon. Clini-cal Journal of Gastroenterology, 14, 608-612.
https://doi.org/10.1007/s12328-020-01301-6
|
[11]
|
陈晨, 刘德春, 从龙龙, 等. 基于阳性淋巴结数的进展期胆囊癌患者生存列线图预测模型[J]. 中华肝脏外科手术学电子杂志, 2018, 7(4): 274-279.
|
[12]
|
Lee, S.E., Kim, K.S., Kim, W.B., et al. (2014) Practical Guidelines for the Surgical Treatment of Gallbladder Cancer. Journal of Korean Medi-cal Science, 29, 1333-1340. https://doi.org/10.3346/jkms.2014.29.10.1333
|
[13]
|
王健东, 全志伟. 胆囊癌的综合治疗[J]. 中华消化外科杂志, 2011, 10(2): 93-95.
|
[14]
|
杨庆芬, 郭建. 胆囊癌与慢性胆囊炎的CT鉴别诊断价值[J]. 影像研究与医学应用, 2021, 5(18): 14-15.
|
[15]
|
张剑. 胆囊癌发病相关危险因素的研究进展[J]. 现代医药卫生, 2022, 38(1): 85-89.
|
[16]
|
Llovet, J.M., De Baere, T., Kulik, L., Haber, P.K., Greten, T.F., Meyer, T. and Lencioni, R. (2021) Locoregional Therapies in the Era of Molecular and Immune Treatments for Hepatocellular Carcinoma. Nature Reviews Gastroenterology & Hepatology, 18, 293-313. https://doi.org/10.1038/s41575-020-00395-0
|